biochemicals

Solazyme and Dow Chemical Form Algae Partnership

By Joseph Baker on March 9, 2011

Tags: algae, algae feedstock, algae-based biofuels, algal oil, bio-based dielectric fluids, biochemicals, Solazyme, Solazyme Inc., The Dow Chemical Company

Just a week after The Dow Chemical Company (NYSE: DOW) committed US$100 million to reduce its carbon footprint the company

LS9 Raises Another $30 Million to Develop Renewable Petroleum

By Nathanael Baker on December 21, 2010

Tags: biochemicals, biotechnology, BlackRock, cellulosic biofuels, CTTV Investments LLC, Flagship Ventures, Khosla Ventures, Lightspeed Venture Partners, LS9, LS9 Inc., Renewable Petroleum, venture capital

Biotechnology startup company, LS9, Inc. has completed has successfully raised US$30 million in venture capital funding.

Part III of Q & A With Charles Eggert, CEO of OPXBIO: "Current State of Affairs of Biofuels & Policy"

By Robert Gluck on June 23, 2010

Tags: Interview With OPXBIO, OPX Biotechnologies, Q A With OPX Biotechnology, algae, bio-based chemistry, biochemicals, biofuels, carbon dioxide, Charles Eggert, government incentives, hydrogen, OPX Biotechnologies, OPXBIO, biofuels, Charles Eggert, chemicals, Robert Gluck

In my third part of my 3 part Q & A with Charles Eggert, CEO of OPX Biotechnologies, he discusses the current state of affairs in the biofuels industry and policy.

ROBERT GLUCK: How do you view the current state of affairs of the American biofuels industry? Biochemicals industry?

Part I of Q & A With OPX Biotechnologies' CEO Charles Eggert: "On the Cutting EDGE of Biotech"

By Robert Gluck on June 17, 2010

In this first part of my three part interview with OPX Biotechnology’s President and CEO Charles Eggert, he discusses his background, this history and mission of OPX and the company’s efficiency directed genome engineering (EDGE) technology.

ROBERT GLUCK: Please tell our readers a little bit about your background.

New Report Says Glycos Biotechnolgies Offers Evolutionary Microbial Conversion Technology

By Robert Gluck on December 30, 2009

Tags: Glycos Biotechnologies Inc., Accenture, Betting on Science, Disruptive Technologies in Transport Fuels, biochemicals, biofuel, bioplastics, cellulosic feedstocks, Glycos Biotechnologies Inc., high-yield fuels, microbial conversion technology, Rich Cilento, biofuels, chemical, chemicals, energy, food

A new report identified Glycos Biotechnologies Inc. as offering an evolutionary microbial conversion technology that uniquely produces high-value chemicals and fuels from disadvantaged low cost feedstocks.